“…Loomis, 1959Loomis, , 1961, the sequence of events involved in the disposal of the injected polymer is still not fully understood. Up to the present, studies on the metabolic fate of heparin have been based on observations made after the injection of unlabelled biosynthetic preparations of the polymer (Wilander & Holmgren, 1938;Wilander, 1939;Jacques, 1939;Reinert & Winterstein, 1939;Copley & Schendorf, 1941;Piper, 1947; Jaques, Napke & Levy, 1953), of preparations labelled biosynthetically with radioactive sulphate (Eiber, Danishefsky & Borelli, 1958;Danishefsky & Eiber, 1959;Loomis, 1961;Day, Green & Robinson, 1962) and of semi-chemically synthesized material prepared by the selective N-resulphation with trimethylamine-[35S]sulphur trioxide of N-desulphated commercial heparin (Levy & Petracek, 1962). The earlier reports dealt mainly with the urinary excretion of the apparently unchanged polymer, but in the later work attention has been given to the tissue distribution of radioactivity and to the appearance of inorganic [35S]sulphate, detectable in the tissues or in the urine, after the injection of the 35S-labelled materials.…”